| Task Name | Dataset Name | SOTA Result | Trend | |
|---|---|---|---|---|
| Survival Prediction | TCGA-BRCA (5-fold cross-validation) | C-Index0.744 | 54 | |
| Cancer Classification | TCGA-BRCA | AUC98.8 | 47 | |
| Survival Prediction | TCGA-BRCA (test) | Concordance Index (CI)0.81 | 41 | |
| Weakly Supervised Classification | TCGA-BRCA Few-shot | Accuracy88.23 | 36 | |
| Slide-Level Classification | TCGA-BRCA (10-fold cross-validation) | F1 Score86.6 | 17 | |
| HER2 Status Prediction | TCGA-BRCA internal cohort | AUC (%)95.76 | 14 | |
| PR Status Prediction | TCGA-BRCA internal cohort | AUC91.79 | 14 | |
| ER Status Prediction | TCGA-BRCA internal cohort | AUC95.81 | 14 | |
| Tumor Segmentation | TCGA-BRCA (target) | DSC0.7008 | 13 | |
| Cancer Subtyping | TCGA-BRCA (test) | Accuracy94.4 | 12 | |
| Slide-Level Subtyping | TCGA-BRCA 100% (train) | Macro AUC87.4 | 9 | |
| Slide-Level Subtyping | TCGA-BRCA (25% train) | Macro AUC0.821 | 9 | |
| HRD prediction | TCGA-BRCA | AUROC (>42)0.8367 | 8 | |
| Whole Slide Image Classification | TCGA-BRCA (five-fold cross-validation) | ACC90.43 | 8 | |
| WSI classification | TCGA-BRCA | Balanced Accuracy89.2 | 7 | |
| Cancer Subtyping | TCGA-BRCA (NIND=2) (IND) | AUC Gain1.67 | 5 | |
| Cancer Subtyping | TCGA-BRCA (NIND=2) (OOD) | AUC Gain5.82 | 5 | |
| Cancer Subtyping | TCGA-BRCA NIND=1 (IND) | AUC Gain4.34 | 5 | |
| Image Classification | TCGA-BRCA (test) | Accuracy93.47 | 3 | |
| Prognosis Prediction | TCGA-BRCA | IBS0.087 | 2 |